Captor Therapeutics S.A. Financial Flexibility Index
Captor Therapeutics S.A. financial flexibility index. Captor Therapeutics S.A. (CTX) has a Financial Flexibility Index of -1.02x as of September 2025. Free cash flow of zł-11.51 Million (operating CF zł-11.51 Million minus capex zł0.00) represents -1% of total liabilities (zł11.27 Million). See CTX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Captor Therapeutics S.A. (2017–2024)
Financial flexibility index of Captor Therapeutics S.A. from 2017 to 2024. Historical Financial Flexibility Index trend for Captor Therapeutics S.A. across 8 annual periods. Explore how well can Captor Therapeutics S.A. service its debt to assess how comfortably operating cash covers total debt obligations.
Captor Therapeutics S.A. Financial Flexibility Index by Year (2017–2024)
Captor Therapeutics S.A. financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Captor Therapeutics S.A.. For the full cash flow conversion analysis, see CTX operating cash flow.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.37x | zł-31.45 Million | zł-31.88 Million | zł23.02 Million | ▲ +22.0% |
| 2023 | -1.75x | zł-49.20 Million | zł-52.20 Million | zł28.07 Million | ▼ -32.5% |
| 2022 | -1.32x | zł-22.06 Million | zł-22.95 Million | zł16.68 Million | ▼ -9.5% |
| 2021 | -1.21x | zł-23.36 Million | zł-28.47 Million | zł19.34 Million | ▼ -8346.5% |
| 2020 | -0.01x | zł-383.00K | zł-595.00K | zł26.78 Million | ▼ -106.5% |
| 2019 | 0.22x | zł4.62 Million | zł4.39 Million | zł21.02 Million | ▲ +258.5% |
| 2018 | -0.14x | zł-2.03 Million | zł-2.13 Million | zł14.63 Million | ▼ -133.0% |
| 2017 | 0.42x | zł2.10 Million | zł2.10 Million | zł4.98 Million | — |